Article Information
History
- January 20, 2021.
Article Versions
- Version 1 (June 24, 2020 - 12:07).
- Version 2 (November 6, 2020 - 20:47).
- You are currently viewing Version 3 of this article (January 20, 2021 - 20:03).
- View Version 4, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Mikhail Vysotskiy1,2,3,4,7,
- Xue Zhong5,6,7,
- Tyne W. Miller-Fleming5,6,
- Dan Zhou5,6,
- Autism Working Group of the Psychiatric Genomics Consortium^,
- Bipolar Disorder Working Group of the Psychiatric Genomics Consortium^,
- Schizophrenia Working Group of the Psychiatric Genomics Consortium^,
- Nancy J. Cox5,6 and
- Lauren A Weiss1,2,3,*
- 1Department of Psychiatry and Behavioral Sciences, University of California San Francisco, San Francisco, CA, 94143 USA
- 2Institute for Human Genetics, University of California San Francisco, San Francisco, CA, 94143 USA
- 3Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA, 94143, USA
- 4Pharmaceutical Sciences and Pharmacogenomics Graduate Program, University of California San Francisco, San Francisco, CA, 94143 USA
- 5Division of Genetic Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, 37232, USA
- 6Vanderbilt Genetics Institute, Nashville, TN, 37232, USA
- ↵*Corresponding author, Lauren A. Weiss 401 Parnassus Ave., A104 San Francisco CA 94143 Phone: 415-476-7650 Fax: 415-476-7970 lauren.weiss{at}ucsf.edu
↵7 These authors contributed equally to this work